Nexgel Inc Total Liabilities

Latest as of June 2026: $20.98 Million USD

Nexgel Inc total liabilities. Based on the latest financial reports, Nexgel Inc (NXGL) has total liabilities worth $20.98 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Nexgel Inc (NXGL) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Nexgel Inc (2016–2025)

Total liabilities of Nexgel Inc from 2016 to 2025. This chart illustrates how Nexgel Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Nexgel Inc (NXGL) investment intensity to see how much of total assets are deployed in long-term investments.

Nexgel Inc Competitors by Total Liabilities

The table below lists competitors of Nexgel Inc ranked by their total liabilities.

Company Country Total Liabilities
Mortgage Advice
LSE:MAB1
UK GBX93.95 Million
Helical Bar Plc
LSE:HLCL
UK GBX171.10 Million
SKONEC Entertainment Co. Ltd.
KQ:276040
Korea ₩6.33 Billion
Montanaro European Smaller Companies Trust plc
LSE:MTE
UK GBX20.66 Million
Softimat S.A.
BR:SOFT
Belgium €867.00K
Freedom Care Group Holdings Ltd
AU:FCG
Australia AU$336.00K
Vectus Biosystems Ltd
AU:VBS
Australia AU$1.04 Million
Sriwahana
JK:SWAT
Indonesia Rp426.23 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Nexgel Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Nexgel Inc total assets.

Liquidity & Leverage Metrics

Nexgel Inc Total Liabilities Ratios Explained

Nexgel Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.43 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 4.24 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.79 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nexgel Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nexgel Inc (2016–2025)

The table below shows the annual total liabilities of Nexgel Inc from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 $5.57 Million +13.60%
2024-12-31 $4.90 Million +2.38%
2023-12-31 $4.79 Million +76.07%
2022-12-31 $2.72 Million -44.47%
2021-12-31 $4.90 Million +124.06%
2020-12-31 $2.19 Million +44.77%
2019-12-31 $1.51 Million +229.69%
2018-12-31 $458.00K +70.26%
2017-12-31 $269.00K -42.40%
2016-12-31 $467.00K --

About Nexgel Inc

NASDAQ:NXGL USA Medical Instruments & Supplies
Market Cap
$43.67 Million
Market Cap Rank
#29552 Global
#6039 in USA
Share Price
$4.48
Change (1 day)
+18.21%
52-Week Range
$0.15 - $5.80
All Time High
$5.80
About

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It a… Read more